Cartesian’s vision is to cure disease by RNA engineering any cell, to deliver to any tissue, any combination of therapies. To realize its vision, Cartesian uses the RNA Armory®, its proprietary cell therapy platform, to engineer combinations of RNA therapies into cells, and targets these cells precisely to the site of disease. The company is currently conducting multiple clinical trials for patients with autoimmune, oncologic and respiratory disorders.
Cartesian operates its wholly-owned, state-of-the-art GMP manufacturing facility in Gaithersburg, MD. Cartesian’s commanding IP position benefits in part from a broad, exclusive patent license from the National Cancer Institute.